» Articles » PMID: 3422644

Specificities and Sensitivities of Three Systems for Determination of Antibodies to Human Immunodeficiency Virus by Electrophoretic Immunoblotting

Overview
Specialty Microbiology
Date 1988 Jan 1
PMID 3422644
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Electrophoretic immunoblotting (EIB [Western blotting]) has emerged as the major method for verification of seropositivity for human immunodeficiency virus (HIV) and therefore needs to be thoroughly characterized. The specificities of three EIB systems, our own and two commercial systems, were studied with anticellular sera and serial dilutions of human sera. We demonstrated that in one system, anti-HLA classes I and II gave bands comigrating with viral proteins, which can be controlled by EIB with uninfected H9 cells. In addition, animal antisera, including anti-immunoglobulin enzyme conjugates, occasionally reacted with HIV gag proteins, necessitating appropriate controls. Whereas none of 10 blood donors reacted at the standard dilution in serum (1/100 or 1/400) in any of the three systems, 6, 1, and 2 of 10 donors reacted with p24, p55, or both at a dilution of 1/10 for the three systems tested. Thus, nonspecific reactions can arise in several ways and justify critical EIB interpretation. The sensitivity of the three systems was studied by comparative titrations and direct quantification of bound immunoglobulin G (IgG). In the titrations with all three, the minor anti-HIV bands p53 and p64, coded from pol, were often detectable in higher dilutions than were antibodies to any other HIV protein. The minimum visible amounts of IgG bound per HIV protein band estimated by extra- and interpolation in densitometric curves and liquid scintillation counting of radiolabeled patient IgG were approximately 0.1, 0.05, and 0.02 ng per band in the three systems. One of the commercial systems had both the highest sensitivity and highest specificity.

Citing Articles

Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Guan M Clin Vaccine Immunol. 2007; 14(6):649-59.

PMID: 17409223 PMC: 1951092. DOI: 10.1128/CVI.00393-06.


Quantification of immunoglobulin on electrophoretic immunoblot strips as a tool for human immunodeficiency virus serodiagnosis.

Blomberg J, Klasse P J Clin Microbiol. 1988; 26(1):111-5.

PMID: 3422645 PMC: 266207. DOI: 10.1128/jcm.26.1.111-115.1988.


Agreement study between two laboratories of immunofluorescence as a confirmatory test for human immunodeficiency virus type 1 antibody screening.

Mahony J, Rosenthal K, Chernesky M, Castriciano S, Scheid E, Blajchman M J Clin Microbiol. 1989; 27(6):1234-7.

PMID: 2666438 PMC: 267533. DOI: 10.1128/jcm.27.6.1234-1237.1989.


Immunoblotting and dot blotting.

Stott D J Immunol Methods. 1989; 119(2):153-87.

PMID: 2656867 PMC: 7172508. DOI: 10.1016/0022-1759(89)90394-3.


Quantitative western immunoblotting analysis in survey of human immunodeficiency virus-seropositive patients.

Schiavini D, Puel J, Averous S, Bazex J J Clin Microbiol. 1989; 27(9):2062-6.

PMID: 2506222 PMC: 267739. DOI: 10.1128/jcm.27.9.2062-2066.1989.


References
1.
Schupbach J, Popovic M, Gilden R, Gonda M, Sarngadharan M, Gallo R . Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science. 1984; 224(4648):503-5. DOI: 10.1126/science.6200937. View

2.
Blomberg J, Klasse P . Quantification of immunoglobulin on electrophoretic immunoblot strips as a tool for human immunodeficiency virus serodiagnosis. J Clin Microbiol. 1988; 26(1):111-5. PMC: 266207. DOI: 10.1128/jcm.26.1.111-115.1988. View

3.
Weiss S, Mann D, Murray C, Popovic M . HLA-DR antibodies and HTLV-III antibody ELISA testing. Lancet. 1985; 2(8447):157. DOI: 10.1016/s0140-6736(85)90261-2. View

4.
Hunter J, Menitove J . HLA antibodies detected by ELISA HTLV-III antibody kits. Lancet. 1985; 2(8451):397. DOI: 10.1016/s0140-6736(85)92544-9. View

5.
Mortimer P, Parry J, Mortimer J . Which anti-HTLV III/LAV assays for screening and confirmatory testing?. Lancet. 1985; 2(8460):873-7. DOI: 10.1016/s0140-6736(85)90136-9. View